Maitreya Medicare (MAITREYA)₹117.55+0.90%Hospital
In the Sep 2026 quarter (consolidated), Maitreya Medicare reported sales of ₹23.71 Cr, down 0.0% from Sep 2025, and net profit of −₹0.95 Cr. For the year to Mar 2026, sales were ₹42 Cr and net profit −₹2.48 Cr.
Company filings, consolidated accounts; latest reported quarter Sep 2026
| Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|
| Sales | 24.82 | 23.04 | 24.38 | 22.33 | 23.72 | 21.17 | 23.71 |
| Expenses | 20.26 | 21.87 | 21.20 | 20.63 | 22.68 | 22.68 | 22.08 |
| Operating Profit | 4.55 | 1.15 | 3.17 | 1.69 | 1.03 | −1.48 | 1.64 |
| OPM % | 18.4% | 5.1% | 13.1% | 7.7% | 4.4% | −7.0% | 7.0% |
| Other Income | 0.06 | 0.23 | 0.20 | 0.39 | 0.24 | 0.77 | 0.38 |
| Interest | 0.38 | 0.47 | 0.46 | 0.36 | 0.42 | 1.07 | 1.26 |
| Depreciation | 0.65 | 0.65 | 0.67 | 0.85 | 0.80 | 0.74 | 1.21 |
| Profit before tax | 3.59 | 0.29 | 2.27 | 0.88 | 0.04 | −2.53 | −0.44 |
| Tax % | 28.5% | 67.9% | 26.2% | 83.2% | 160.1% | −4.0% | 118.7% |
| Net Profit | 2.57 | 0.10 | 1.68 | 0.16 | −0.05 | −2.44 | −0.95 |
| EPS (Rs) | 5.15 | 0.12 | 2.45 | 0.21 | −0.05 | −3.58 | −1.38 |
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Sales | 56.00 | 49.41 | 39.33 | 46.13 | 45.05 | 42.00 |
| Expenses | 48.71 | 46.05 | 32.05 | 40.12 | 40.16 | 42.33 |
| Operating Profit | 7.23 | 3.36 | 7.24 | 5.99 | 4.87 | −0.29 |
| OPM % | 13.0% | 6.8% | 18.6% | 13.1% | 10.9% | −0.7% |
| Other Income | 0.44 | 0.34 | 0.54 | 0.31 | 0.58 | 0.90 |
| Interest | 0.81 | 0.77 | 0.58 | 0.85 | 0.81 | 1.49 |
| Depreciation | 1.10 | 1.33 | 1.30 | 1.28 | 1.51 | 1.53 |
| Profit before tax | 5.78 | 1.59 | 5.94 | 4.20 | 3.14 | −2.42 |
| Tax % | 26.6% | 28.8% | 28.2% | 29.2% | 42.6% | 2.5% |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Profit | 4.25 | 1.15 | 4.27 | 2.98 | 1.83 | −2.48 |
| EPS (Rs) | 8.47 | 2.27 | 8.56 | 4.37 | 2.68 | −3.64 |
| Dividend payout % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Equity Capital | 0.00 | 0.00 | 4.95 | 6.76 | 6.77 | 6.76 |
| Reserves | 3.86 | 4.71 | 3.80 | 18.07 | 19.95 | 17.49 |
| Borrowings | 14.27 | 12.40 | 11.62 | 11.12 | 10.55 | 27.97 |
| Other Liabilities | 7.17 | 7.40 | 8.57 | 7.95 | 10.75 | 16.32 |
| Total Liabilities | 25.30 | 24.51 | 28.94 | 43.90 | 48.02 | 68.54 |
| Fixed Assets | 13.86 | 13.42 | 11.62 | 14.33 | 15.27 | 40.87 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 1.06 | 0.31 | 0.67 | 1.46 | 0.03 | 0.04 |
| Other Assets | 10.38 | 10.78 | 16.65 | 28.11 | 32.72 | 27.63 |
| Inventories | 1.36 | 0.70 | 0.81 | 0.62 | 0.60 | 0.85 |
| Trade receivables | 4.88 | 5.86 | 9.71 | 13.68 | 14.92 | 11.00 |
| Cash & equivalents | 2.90 | 1.14 | 1.93 | 6.55 | 7.90 | 8.65 |
| Total Assets | 25.30 | 24.51 | 28.94 | 43.90 | 48.02 | 68.54 |
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Cash from operating activity | 4.46 | 0.09 | 2.60 | −2.51 | 5.07 | 8.07 |
| Cash from investing activity | −5.06 | −0.01 | 0.35 | −5.43 | −7.36 | −26.70 |
| Cash from financing activity | 2.17 | −1.87 | −1.60 | 12.23 | 3.68 | 19.10 |
| Net cash flow | 1.56 | −1.81 | 1.37 | 4.28 | 1.37 | 0.37 |
| Capex | 5.63 | 0.91 | 0.04 | 1.62 | 2.39 | 27.30 |
| Free cash flow | −1.18 | −0.83 | 3.17 | −4.12 | 2.69 | −19.07 |
| CFO / OP % | 76.9% | 53.9% | 39.9% | −12.1% | 133.9% | −2,727.1% |
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Debtor days | 31 | 42 | 89 | 108 | 120 | 95 |
| Inventory days | 69 | 41 | 70 | 40 | 37 | 63 |
| Days payable | 258 | 222 | 320 | 207 | 200 | 303 |
| Cash conversion cycle | −158 | −139 | −160 | −59 | −43 | −145 |
| Working capital days | −3 | 4 | 44 | 74 | 75 | −10 |
| ROCE % | — | 12.3% | 32.8% | 17.3% | 10.6% | −1.9% |
For the Sep 2026 quarter, Maitreya Medicare reported sales of ₹23.71 Cr, down 0.0% year on year and net profit of −₹0.95 Cr. The operating margin was 7.0%.
Maitreya Medicare's sales for the year to Mar 2026 were ₹42 Cr.
Net profit for the year to Mar 2026 was −₹2.48 Cr. Earnings per share over the same trailing period were ₹−3.64.
Maitreya Medicare reported borrowings of ₹27.97 Cr at Mar 2026, against cash and equivalents of ₹8.65 Cr.
Cash from operations was ₹8.07 Cr in the year to Mar 2026; after capital spending, free cash flow was −₹19.07 Cr.